| Authors: |
Pons-Riverola A; Cardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom; Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; BioHeart Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Llamedo MC; Cardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom., Ruane L; Cardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom., Kapetanakis S; Guy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom., Wechalekar K; Department of Nuclear Medicine, Royal Brompton Hospital, London, United Kingdom., Chak PK; Department of Histopathology, The Royal Marsden Hospital, London, United Kingdom., D'Silva A; Guy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom; School of Cardiovascular and Metabolic Medicine and Science, King's College London, London, United Kingdom., Chau I; The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Lyon AR; Cardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom., Nazir MS; Cardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom; School of Biomedical Engineering and Imaging Sciences, King's College London, Guy's and St Thomas' Hospital, London, United Kingdom. Electronic address: sohaib.nazir@kcl.ac.uk. |
